Zobrazeno 1 - 10
of 14
pro vyhledávání: '"García-Campelo MR"'
Autor:
Mariano Provencio, Roberto Serna-Blasco, Ernest Nadal, Amelia Insa, M. Rosario García-Campelo, Joaquín Casal Rubio, Manuel Dómine, Margarita Majem, Delvys Rodríguez-Abreu, Alex Martínez-Martí, Javier De Castro Carpeño, Manuel Cobo, Guillermo López Vivanco, Edel Del Barco, Reyes Bernabé Caro, Nuria Viñolas, Isidoro Barneto Aranda, Santiago Viteri, Eva Pereira, Ana Royuela, Virginia Calvo, Javier Martín-López, Francisco García-García, Marta Casarrubios, Fernando Franco, Estela Sánchez-Herrero, Bartomeu Massuti, Alberto Cruz-Bermúdez, Atocha Romero
Publikováno v:
JOURNAL OF CLINICAL ONCOLOGY
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Universitat Rovira i virgili (URV)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Scientia
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Universitat Rovira i virgili (URV)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Scientia
PURPOSE Neoadjuvant chemotherapy plus nivolumab has been shown to be effective in resectable non–small-cell lung cancer (NSCLC) in the NADIM trial (ClinicalTrials.gov identifier: NCT03081689 ). The 3-year overall survival (OS) and circulating tumor
Autor:
Gomez-Randulfe I; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Silva Díaz S; Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain., Escriu C; Medical Oncology, The Clatterbridge Cancer Centre, Liverpool, UK., Mohammed S; Oncology Department, Maidstone Hospital, Maidstone, UK., Shah R; Oncology Department, Maidstone Hospital, Maidstone, UK., Benitez Fuentes JD; Clinical Oncology, Velindre Cancer Centre NHS Wales, Cardiff, UK., Cox S; Clinical Oncology, Velindre Cancer Centre NHS Wales, Cardiff, UK., Monaca F; Medical Oncology Department, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Bria E; Medical Oncology Department, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., García-Campelo MR; Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain., Crook B; Royal Cornwall Hospital, Truro, UK., Talbot T; Royal Cornwall Hospital, Truro, UK., Leporati R; Oncology Department, Istituto Nazionale dei Tumori di Milano - Fondazione IRCCS, Milan, Italy., Balachandran K; Oncology Department, Chelsea and Westminster Hospital NHS Trust, London, UK., Newsom-Davis T; Oncology Department, Chelsea and Westminster Hospital NHS Trust, London, UK., Hughes S; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Cove-Smith L; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Taylor P; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Blackhall F; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Califano R; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK Division of Cancer Sciences, The University of Manchester, Manchester, UK.
Publikováno v:
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2024 Sep 19; Vol. 16, pp. 17588359241272957. Date of Electronic Publication: 2024 Sep 19 (Print Publication: 2024).
Autor:
Calvo V; Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Manuel de Falla 1, Majadahonda, 28222, Madrid, Spain. vircalvo@hotmail.com., Camps C; Hospital General Universitario, Valencia, Spain., Carcereny E; Institut Català d'Oncologia, Badalona, Spain., Cobo M; Hospital Regional Universitario, Málaga, Spain., Dómine M; Hospital Universitario Fundación Jiménez Díaz, IIS-FJD, Madrid, Spain., García Campelo MR; Complexo Hospitalario Universitario A Coruña, A Coruña, Spain., González Larriba JL; Hospital Clínico San Carlos, Madrid, Spain., Guirado M; Hospital General de Elche, Alicante, Spain., Hernando-Trancho F; Hospital Clínico San Carlos, Madrid, Spain., Massutí B; Hospital General Universitario Dr. Balmis, Alicante, Spain., Nadal E; Institut Català d'Oncologia, l'Hospitalet de Llobregat, Barcelona, Spain., Rodríguez-Abreu D; Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain., Sánchez A; Consorcio Hospital Provincial, Castellón, Spain., Sullivan IG; Hospital Santa Creu i Sant Pau, Barcelona, Spain., Provencio M; Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Manuel de Falla 1, Majadahonda, 28222, Madrid, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Mar; Vol. 26 (3), pp. 597-612. Date of Electronic Publication: 2023 Aug 31.
Autor:
Provencio M; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Serna-Blasco R; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Nadal E; Institut Català d'Oncologia, L'Hospitalet De Llobregat, Barcelona, Spain., Insa A; Fundación INCLIVA, Hospital Clínico Universitario de Valencia, Valencia, Spain., García-Campelo MR; Hospital Universitario A Coruña, A Coruña, Spain., Casal Rubio J; Hospital Universitario de Vigo, Pontevedra, Spain., Dómine M; Hospital Universitario Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain., Majem M; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Rodríguez-Abreu D; Hospital Insular de Gran Canaria, Las Palmas, Spain., Martínez-Martí A; Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain., De Castro Carpeño J; Hospital Universitario La Paz, Madrid, Spain., Cobo M; Hospital Universitario Regional de Malaga, Spain., López Vivanco G; Hospital Universitario Cruces, Barakaldo, Spain., Del Barco E; Hospital Universitario de Salamanca, Salamanca, Spain., Bernabé Caro R; Hospital Universitario Virgen del Rocio, Seville, Spain., Viñolas N; Hospital Clínic, Barcelona, Spain., Barneto Aranda I; Hospital Universitario Reina Sofia, Córdoba, Spain., Viteri S; Instituto Oncológico Dr Rosell. Hospital Universitario Quiron Dexeus, Grupo QuironSalud, Barcelona, Spain., Pereira E; Spanish Lung Cancer Group, Barcelona, Spain., Royuela A; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Calvo V; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Martín-López J; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., García-García F; Centro de Investigación Principe Felipe, Valencia, Spain., Casarrubios M; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Franco F; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Sánchez-Herrero E; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.; Atrys Health, Barcelona, Spain., Massuti B; Hospital General de Alicante, Alicante, Spain., Cruz-Bermúdez A; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Romero A; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Sep 01; Vol. 40 (25), pp. 2924-2933. Date of Electronic Publication: 2022 May 16.
Autor:
Filippi AR; Department of Radiation Oncology, Fondazione IRCCS Policlinico San Matteo & University of Pavia, Pavia 27100, Italy., Dziadziuszko R; Department of Oncology & Radiotherapy, Medical University of Gdansk, Gdansk 80-210, Poland., García Campelo MR; Medical Oncology Unit, University Hospital A Coruña, A Coruña 15006, Spain., Paoli JB; Service Radiothérapie, Hôpital Privé Clairval, Marseille 13009, France., Sawyer W; Global Medicines Development, AstraZeneca, Cambridge, CB2 0AA, UK., Díaz Pérez IE; Global Medical Affairs, AstraZeneca, Gaithersburg, MD 20878, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2021 Dec; Vol. 17 (34), pp. 4657-4663. Date of Electronic Publication: 2021 Nov 15.
Autor:
García Campelo MR; Medical Oncology, University Hospital A Coruña (XXIAC-SERGAS), 15006 A Coruña, Spain., Arriola E; Medical Oncology, Hospital Universitari del Mar-CIBERONC, 08003 Barcelona, Spain., Campos Balea B; Medical Oncology, Hospital Universitario Lucus Augusti, 27003 Lugo, Spain., López-Brea M; Medical Oncology, Hospital Marqués de Valdecilla, 39008 Santander, Spain., Fuentes-Pradera J; Medical Oncology, Hospital Universitario Nuestra Señora de Valme, 41014 Sevilla, Spain., de Castro Carpeno J; Medical Oncology, Hospital Universitario La Paz, IdiPAZ, 28029 Madrid, Spain., Aguado C; Medical Oncology, Hospital Clínico San Carlos, 28040 Madrid, Spain., Pérez Parente D; Medical Affairs Department, Roche Farma S.A., 28042 Madrid, Spain., de Oro Pulido F; Medical Affairs Department, Roche Farma S.A., 28042 Madrid, Spain., Ruiz-Gracia P; Medical Affairs Department, Roche Farma S.A., 28042 Madrid, Spain., Rodríguez-Abreu D; Medical Oncology, Hospital Universitario Insular de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2021 Oct 04; Vol. 10 (19). Date of Electronic Publication: 2021 Oct 04.
Autor:
Ferrarotto R; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Anderson I; St Joseph Heritage Healthcare, Santa Rosa, CA, USA., Medgyasszay B; Veszprém County Lung Medicine Institute, Veszprém, Hungary., García-Campelo MR; University Hospital A Coruña, A Coruña, Spain., Edenfield W; Prisma Health Cancer Institute, Greenville, SC, USA., Feinstein TM; Piedmont Cancer Institute, Atlanta, GA, USA., Johnson JM; Thomas Jefferson University Hospital, Philadelphia, PA, USA., Kalmadi S; Ironwood Cancer & Research Center, Chandler, AZ, USA., Lammers PE; Baptist Cancer Center, Memphis, TN, USA., Sanchez-Hernandez A; Hospital Provincial de Castellon, Castelló, Spain., Pritchett Y; G1 Therapeutics, Inc., Research Triangle Park, NC, USA., Morris SR; G1 Therapeutics, Inc., Research Triangle Park, NC, USA., Malik RK; G1 Therapeutics, Inc., Research Triangle Park, NC, USA., Csőszi T; Hetenyi Geza Korhaz, Szolnok, Hungary.
Publikováno v:
Cancer medicine [Cancer Med] 2021 Sep; Vol. 10 (17), pp. 5748-5756. Date of Electronic Publication: 2021 Aug 18.
Autor:
Arias Ron D; Medical Oncology Department, University Hospital Complex of Ourense, Ourense, Spain. Electronic address: david.arias.ron@gmail.com., Areses Manrique MC; Medical Oncology Department, University Hospital Complex of Ourense, Ourense, Spain., Mosquera Martínez J; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain., García González J; Medical Oncology Department, Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS), Santiago de Compostela 15706, Spain., Afonso Afonso FJ; Medical Oncology Department, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain., Lázaro Quintela M; Medical Oncology Department, Hospital Alvaro Cunqueiro, Vigo, Spain., Fernández Núñez N; Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain., Azpitarte Raposeiras C; Medical Oncology Department, Complejo Hospitalario de Pontevedra, Pontevedra, Spain., Amenedo Gancedo M; Centro Oncológico Coruña, A Coruña, Spain., Santomé Couto L; Medical Oncology Department, Hospital POVISA, Pontevedra, Spain., García Campelo MR; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain., Muñoz Iglesias J; Medical Oncology Department, University Hospital Complex of Ourense, Ourense, Spain., Ruiz Bañobre J; Medical Oncology Department, Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS), Santiago de Compostela 15706, Spain., Vilchez Simo R; Medical Oncology Department, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain., Casal Rubio J; Medical Oncology Department, Hospital Alvaro Cunqueiro, Vigo, Spain., Campos Balea B; Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain., Carou Frieiro I; Medical Oncology Department, Complejo Hospitalario de Pontevedra, Pontevedra, Spain., Alonso-Jaudenes Curbera G; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain., Anido Herranz U; Medical Oncology Department, Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS), Santiago de Compostela 15706, Spain., García Mata J; Medical Oncology Department, University Hospital Complex of Ourense, Ourense, Spain., Fírvida Pérez JL; Medical Oncology Department, University Hospital Complex of Ourense, Ourense, Spain.
Publikováno v:
Journal of geriatric oncology [J Geriatr Oncol] 2021 Apr; Vol. 12 (3), pp. 410-415. Date of Electronic Publication: 2020 Dec 21.
Autor:
Provencio M; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain. Electronic address: mprovenciop@gmail.com., Nadal E; Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain., Insa A; Fundación INCLIVA, Hospital Clínico Universitario de Valencia, Valencia, Spain., García-Campelo MR; Hospital Universitario A Coruña, A Coruña, Spain., Casal-Rubio J; Hospital Universitario de Vigo, Pontevedra, Spain., Dómine M; Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Majem M; Hospital de la Santa Creu I Sant Pau, Barcelona, Spain., Rodríguez-Abreu D; Hospital Insular de Gran Canaria, Las Palmas, Spain., Martínez-Martí A; Hospital Universitario e Instituto de Oncología Vall d'Hebron (VHIO), Barcelona, Spain., De Castro Carpeño J; Hospital Universitario La Paz, Madrid, Spain., Cobo M; Hospital Universitario Regional de Málaga, Málaga, Spain., López Vivanco G; Hospital Universitario Cruces, Barakaldo, Spain., Del Barco E; Hospital Universitario de Salamanca, Salamanca, Spain., Bernabé Caro R; Hospital Universitario Virgen del Rocio, Seville, Spain., Viñolas N; Hospital Clínic de Barcelona, Barcelona, Spain., Barneto Aranda I; Hospital Universitario Reina Sofia, Córdoba, Spain., Viteri S; Instituto Oncológico Dr Rosell, Hospital Universitari Dexeus-Grupo Quironsalud, Barcelona, Spain., Pereira E; Spanish Lung Cancer Group, Barcelona, Spain., Royuela A; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain., Casarrubios M; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Salas Antón C; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Parra ER; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wistuba I; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Calvo V; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Laza-Briviesca R; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Romero A; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Massuti B; Hospital General de Alicante, Alicante, Spain., Cruz-Bermúdez A; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2020 Nov; Vol. 21 (11), pp. 1413-1422. Date of Electronic Publication: 2020 Sep 24.
Autor:
Camidge DR; University of Colorado Cancer Center, Aurora, CO., Kim HR; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Ahn MJ; Samsung Medical Center, Seoul, South Korea., Yang JCH; National Taiwan University Hospital, Taipei, Taiwan., Han JY; National Cancer Center, Goyang, South Korea., Hochmair MJ; Department of Respiratory and Critical Care Medicine, Krankenhaus Nord-Klinik Floridsdorf, Vienna, Austria., Lee KH; Chungbuk National University Hospital, Cheongju, South Korea., Delmonte A; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy., García Campelo MR; Complejo Hospitalario Universitario A Coruna, Coruna, Spain., Kim DW; Seoul National University Hospital, Seoul, South Korea., Griesinger F; Pius-Hospital Oldenburg, University of Oldenburg, Oldenburg, Germany., Felip E; Vall d'Hebron University Hospital, Barcelona, Spain., Califano R; The Christie NHS Foundation Trust and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom., Spira A; Virginia Cancer Specialists and US Oncology Research, The Woodlands, TX., Gettinger SN; Yale Cancer Center, New Haven, CT., Tiseo M; University Hospital of Parma, Parma, Italy., Lin HM; Millennium Pharmaceuticals, Cambridge, MA., Gupta N; Millennium Pharmaceuticals, Cambridge, MA., Hanley MJ; Millennium Pharmaceuticals, Cambridge, MA., Ni Q; Millennium Pharmaceuticals, Cambridge, MA., Zhang P; Millennium Pharmaceuticals, Cambridge, MA., Popat S; Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, London, United Kingdom.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Nov 01; Vol. 38 (31), pp. 3592-3603. Date of Electronic Publication: 2020 Aug 11.